<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CF330551-105A-4A80-AC95-14BE0FC2A606"><gtr:id>CF330551-105A-4A80-AC95-14BE0FC2A606</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Atherton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5A75CEC3-448D-47E0-A641-3ED2BD0CA4EC"><gtr:id>5A75CEC3-448D-47E0-A641-3ED2BD0CA4EC</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Delahay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901104"><gtr:id>339C6EBF-0C0A-4B72-B8CA-E34D01A37997</gtr:id><gtr:title>Functional characterisation of a novel type IV secretion system associated with the severe disease marker, dupA</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901104</gtr:grantReference><gtr:abstractText>Helicobacter pylori is a common bacterial infection of the human stomach, affecting approximately half of the world?s population. In most people the infection is harmless, however, in ~20% of infected individuals, H. pylori causes serious disease, including gastric/duodenal ulcers, and gastric cancer. The presence of several genes encoded within the H. pylori genome have been shown to be putative markers for the development of severe disease coincident with H. pylori infection. We have shown that these markers are part of a single large cluster of genes which encode proteins known to assemble into a specialised bacterial ?type IV? secretion system (T4SS). Bacterial T4SSs function to transport protein-DNA complexes into other bacterial cells in the exchange of genetic material, or in the case of bacteria which cause diseases in plants, function to transport and integrate bacterial DNA into the host plant cell chromosome. This latter process genetically transforms the plant cell and initiates the development of disease.
Due to previously established association of individual H. pylori T4SS genes with disease and the presence of certain components within the T4SS gene cluster, which we call tfs4, we hypothesise that tfs4 may similarly transport protein-DNA complexes into infected cells within the human stomach. We propose to determine whether tfs4 activity (on/off status) similarly associates with disease presentation in strains isolated from infected individuals and to fully investigate the function of tfs4. 
In plant pathogens, a protein called VirD2 is responsible for the transport and integration of bacterial DNA into the host plant cell chromosome. H. pylori tfs4 encodes a similar VirD2 protein. We will determine what other proteins and specific DNA sequences tfs4 VirD2 binds to and establish whether it can be transported, in complex with bacterial DNA, via the novel H. pylori T4SS to different types of human gastric cells. This may reveal a novel, uncharacterised and extremely important underlying mechanism by which H. pylori is able to cause serious diseases, such as gastric cancer in some infected individuals. Our work will be important for determining which strains of H. pylori have the most potential for causing disease and may provide insight into how the tfs4 T4SS can be exploited in future for the treatment of gastric disorders. Our observations will be published in the scientific press, on our publicly accessible websites and potentially also communicated to the national media via our Press Office to capture and stimulate broad public attention.</gtr:abstractText><gtr:technicalSummary>H. pylori colonises the gastric mucosa of over half the world?s population causing gastritis, peptic ulceration and gastric adenocarcinoma. Recent studies identify several marker genes significantly associated with severe clinical outcome of infection encoded within plasticity regions of the H. pylori genome. Our preliminary analyses show that all these marker genes are genetically linked and encoded within a single novel cluster of type IV secretion system (T4SS) genes. This analysis indicates that the activity of the T4SS, termed here tfs4, underlies the development of severe disease associated with H. pylori infection in some human populations. We propose two main avenues of research to investigate tfs4. 
First, we will determine the prevalence and activation status of tfs4 using PCR to screen for complete tfs4 clusters in an extensive collection of geographically diverse clinical strains (400+), then assess activation status using specific antibodies. Association of tfs4 presence/activity with known clinical presentation will be determined using appropriate statistical analysis. 
Second, we will investigate the function of tfs4. Within the tfs4 gene cluster we identify homologues of Agrobacterium tumefaciens genes VirD2 and VirC1 which are critical to the ability of the pathogen to genetically transform host plant cells. In A. tumefaciens, VirD2 functions as an endonuclease to excise and covalently bind to specific transfer(T)-DNA sequences. In association with other Vir proteins it pilots the T-DNA through the T4SS into the host plant cell, where it localises to the nucleus and integrates T-DNA into the host chromosome. These diverse VirD2 activities are dependent upon several sequence motifs which are similarly conserved in the sequence of H. pylori tfs4 VirD2. We will therefore comprehensively investigate the protein-protein and protein-DNA interactions of tfs4 VirD2 in both complex and candidate yeast two hybrid screens, co-immunoprecipitation and column pulldown approaches. We will determine whether VirD2 is translocated to the host cell and confirm its cellular localisation using an established GSK-tag reporter and novel protein transfection approaches in combination with immunostaining and fluorescence microscopy. We will also determine the sequence of DNA to which VirD2 binds and its sequence context. Finally, we will provide preliminary confirmation of tfs4 activity in vivo using immunohistochemical analysis of existing gastric cell samples. Our collective results are anticipated to improve determination of pathogenic potential of H. pylori strains, inform clinical management of infected individuals and present an opportunity for biotechnological exploitation of tfs4 activity for the treatment of gastric diseases in the future.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>408638</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NDDC-BRU open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>02320830-2621-4C60-A58B-57A1380E8A9A</gtr:id><gtr:impact>Approximately 50 people attended throughout the open day (2013). The event is informal and presents an opportunity for members of the public to watch themed demonstrations and freely ask questions about our research and facilities.

No notable impacts other than a good level of engagement with the public</gtr:impact><gtr:outcomeId>oiDhTtj2ND6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2013/june/nottingham-digestive-diseases-biomedical-research-unit-open-day.aspx</gtr:url><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35005</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTG Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>55671A83-D08C-4DFD-B2D8-3B903BCE782F</gtr:id><gtr:outcomeId>icLgExZWFWm</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>57450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vice-Chancellor's Scholarship for Research Excellence (International)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>BEEE5339-6404-46A2-B0C9-6EC53607ED6C</gtr:id><gtr:outcomeId>54608dc1c732f1.41792596</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8920</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Nottingham University Hospitals Charity</gtr:department><gtr:description>Pump-prime funding competition</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Nottingham University Hospitals NHS Trust</gtr:fundingOrg><gtr:id>6F06AE0D-BD2B-41B1-84F1-5E2122BF762E</gtr:id><gtr:outcomeId>56dd9537d50074.08528231</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A method was developed to mine and assemble large contiguous gene clusters (30-40kb in length) from draft H. pylori genome sequences (WGSs). 
The resulting database has provided contextual information to enable a comprehensive survey of H. pylori tfs3 and tfs4 ICE representation in global H. pylori strain populations. The intention is to determine the prevalence and extent of fragmentation of the tfs ICEs in global H. pylori populations, to provide insight into tfs ICE function and inform and enable more discriminatory regional association of ICE types with disease outcome.</gtr:description><gtr:id>481B9D79-E80E-43BB-AFB0-56D8BDF01DC6</gtr:id><gtr:impact>The dataset, annotation and analysis has provided rich context and reference for our ongoing studies and allowed for development of a novel and facile classification of tfs ICE types. The complete dataset will be released in support of a research publication, currently in final stages of preparation (expected mid-2017).</gtr:impact><gtr:outcomeId>546094105fb385.72572035</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>tfs ICE classification</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Identification of H. pylori clinical reference strains, each harboring different variant T4SS types has facilitated the generation of multiple isogenic mutant strains. These are unique to our study and are proving invaluable in the characterisation of T4SS function/activity as each mutant is defined by a defect in a different functional stage of the T4SS pathway. As such we have generated a panel of functional mutants.</gtr:description><gtr:id>8B81D8A9-5916-4993-BE53-1AC72A31FCA0</gtr:id><gtr:impact>Contrary to expectation we have shown different cytokine IL-12 induction profiles from PBMCs co-cultured with different isogenic T4SS mutants. This has led to formulation of new research avenues and provided further insight into T4SS function. Strains are presently available to other Helicobacter research groups within our local environment.</gtr:impact><gtr:outcomeId>FLzkqto28MN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mutant Helicobacter strains</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A polyclonal antibody raised against a secreted and potentially translocated protein raised in rabbits. We are purifying this for use in a range if biological assays to fully characterise VirD2 function. Other non-MRC funding was used in the early development stage of this reagent prior to the current MRC grant support which has enabled further development and significantly expanded use.</gtr:description><gtr:id>DEA8BB1F-9FE3-414B-AB5D-946E4A751DCB</gtr:id><gtr:impact>We have generated a valuable research tool but presently no notable impacts have arisen from its use. This is due to the nature of the investigation whereby we first need to identify an inducer of full secretion system activity (and therefore expression of VirD2) from clinical strains. The antibody is fundamental to the progress of these studies.</gtr:impact><gtr:outcomeId>AdU8EkZX3UF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>VirD2 antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A polyclonal antibody raised against a putative H. pylori secreted protein</gtr:description><gtr:id>2FBB58E8-8A75-43FC-8A27-18958EA2BD61</gtr:id><gtr:impact>Allowing us to examine activity of tfs3/tfs4 and possible translocation of a putative effector protein from H. pylori to a host eukaryotic cell</gtr:impact><gtr:outcomeId>B4Lfv9b7AWG</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>135 antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a rapid method for PCR genotyping of tfs ICE clusters in different Helicobacter pylori clinical strain collections. The method has enabled determination of ICE representation, prevalence and characterisation of variant ICE types and assessment of an association of particular ICE types with clinical outcome.</gtr:description><gtr:id>04C2EEDF-CD38-4B92-AF2F-B7B53AACB8DE</gtr:id><gtr:impact>Typing has enabled identification of 'reference' strains representative of different ICE types for use in functional studies. These strains are being used in our studies and the studies of other H. pylori research groups working within our local environment. The genotyping information will add to a local database to provide a comprehensive description of the virulence profile of different clinical H. pylori isolates.</gtr:impact><gtr:outcomeId>Q16aM9cwdM9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Long PCR typing data</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a research model for study of H. pylori-host epithelial cell interaction mediated by components of the H. pylori tfs3 disease-associated ICEs.
This comprises specific engineering of H. pylori strains for use in co-culture models of infection.</gtr:description><gtr:id>15BB9E6D-26FC-4BB1-845A-C19790CE4F2A</gtr:id><gtr:impact>We have used the model in our research to determine activity of both secretion system and a secreted product. Ongoing work will further exploit the methods developed to fully identify and characterise the repertoire of putative tfs ICE-encoded secretion substrates and define their role in H. pylori host cell interaction and virulence. 
An initial manuscript describing the engineered strains and model is currently in submission for publication.</gtr:impact><gtr:outcomeId>58c2ab0bee5979.67756592</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>H. pylori Tfs T4SS infection model</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>GFP encoding H. pylori reporter plasmid for use in complementation and reporter studies. Shuttle plasmid is a modified version of a previously published construct for improved genetic manipulation of H. pylori.</gtr:description><gtr:id>9872D752-FBEB-4758-B9FD-0A402E9C9066</gtr:id><gtr:impact>We have modified the plasmid to allow its use as a reporter of tfs4 promotor activity in a high throughput assay format. This is enabling us to examine and define the inducers of tfs4 T4SS activity. The assay has enabled greatly accelerated examination of induction conditions.</gtr:impact><gtr:outcomeId>N37jzLtpqTU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Reporter plasmid</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A polyclonal antibody rasied against tfs4 VirB9 protein</gtr:description><gtr:id>8B03A1C8-D0F5-4BDD-A682-E12696E74B20</gtr:id><gtr:impact>Used for monitoring presence or otherwise of the tfs4 T4SS in H. pylori clinical isolates</gtr:impact><gtr:outcomeId>HDVWmPy8i1C</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>VirB9 antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DDD72170-5567-4F6A-BE9A-61EE31F88845</gtr:id><gtr:title>Phylogeographic diversity and mosaicism of theintegrative and conjugative elements.</gtr:title><gtr:parentPublicationTitle>Mobile DNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83755472933bf6e759ed010061a4b194"><gtr:id>83755472933bf6e759ed010061a4b194</gtr:id><gtr:otherNames>Delahay RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a788a2dba6085.46410696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45B56C09-797E-460D-99B4-99A09F5CDFCD</gtr:id><gtr:title>JHP0940 EXPRESSED FROM HELICOBACTER PYLORI INDUCES A PROINFLAMMATORY RESPONSE FROM GASTRIC EPITHELIAL CELLS IN VITRO</gtr:title><gtr:parentPublicationTitle>HELICOBACTER</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93bf7ab3c999b7edd2e4f1b42f7b6191"><gtr:id>93bf7ab3c999b7edd2e4f1b42f7b6191</gtr:id><gtr:otherNames>Alandiyjany M. N.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1083-4389</gtr:issn><gtr:outcomeId>od8HsvDu1ZU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4899189-B157-406B-982D-0620C494E162</gtr:id><gtr:title>THE ROLE OF THE TFS4 TYPE IV SECRETION SYSTEM IN CHROMOSOMAL DNA TRANSFER IN HELICOBACTER PYLORI</gtr:title><gtr:parentPublicationTitle>HELICOBACTER</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd1692488881232f46002da3a54acca2"><gtr:id>bd1692488881232f46002da3a54acca2</gtr:id><gtr:otherNames>Stephens A. S. D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1083-4389</gtr:issn><gtr:outcomeId>CREsu8GwEpw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4082F24-33B2-465A-8A62-053B5959B4D7</gtr:id><gtr:title>Site-specific relaxase activity of a VirD2-like protein encoded within the tfs4 genomic island of Helicobacter pylori.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a9f9cb0772c37f82673df90ec84a25"><gtr:id>f7a9f9cb0772c37f82673df90ec84a25</gtr:id><gtr:otherNames>Grove JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>k6oZi2Njrr4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87BB3C39-178D-4D7D-BF0E-0208EC3785D5</gtr:id><gtr:title>A role for the tfs3 ICE-encoded type IV secretion system in pro-inflammatory signalling by the Helicobacter pylori Ser/Thr kinase, CtkA.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd94c7adb8dffeea1fe219895a685b48"><gtr:id>fd94c7adb8dffeea1fe219895a685b48</gtr:id><gtr:otherNames>Alandiyjany MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd53e2a0cb4.75331012</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901104</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>